Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Mouth Neoplasms 3Carcinoma, Renal Cell 3Breast Neoplasms 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Urinary Tract Infections 1Tongue Neoplasms 1Tobacco Use Disorder 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pancreatic Adenocarcinoma 1Mouth Diseases 1Lymphoid Interstitial Pneumonia 1Lymphatic Metastasis 1Lung Neoplasms 1Lichen Planus 1Leukokeratosis, Hereditary Mucosal 1Klatskin Tumor 1Fanconi Anemia 1Erythroplasia 1Colonic Polyps 1Colonic Neoplasms 1Colonic Diseases 1Carcinoma, Transitional Cell 1

Interventions

Gemcitabine 685130-nm albumin-bound paclitaxel 199Fluorouracil 190Oxaliplatin 177Albumin-Bound Paclitaxel 154Capecitabine 137Leucovorin 133Irinotecan 114Radiotherapy 96Taxes 85pembrolizumab 81Cisplatin 73Erlotinib Hydrochloride 70Radiosurgery 69Nivolumab 56Drug Therapy 56Bevacizumab 54Magnetic Resonance Spectroscopy 51Cyclophosphamide 50folfirinox 45Specimen Handling 43Docetaxel 42Cetuximab 40Biopsy 39irinotecan sucrosofate 38S 1 (combination) 36Pancreaticoduodenectomy 35Blood Specimen Collection 34Surgical Procedures, Operative 31Paclitaxel 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Optical Imaging × Clear all
NCT03033225 2025-07-30

Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study

Mayo Clinic

Phase 2 Completed
13 enrolled 6 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡